Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesOncolytic Viral Therapy of Malignant Glioma
Neurotherapeutics, 07/02/09
Parker JN et al. - Novel approaches to treatment of malignant glioma, the most frequently occurring primary brain tumor, have included the use of a wide range of oncolytic viral vectors. These vectors, either naturally tumor-selective, or engineered as such, have shown promise in the handful of phase I and phase II clinical trials conducted in recent years.
Related Articles
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor
Cancer Gene Therapy, 10/07/09
Relevance Score: 80%
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Oral Oncology, 10/23/09
Relevance Score: 68%
Reactivation of hepatitis B viral infection in inactive HBSAg carriers following anti-tumor necrosis factor-alpha therapy
Journal of Rheumatology, 10/05/09
Relevance Score: 68%
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Relevance Score: 66%
Oncolytic virus therapy for prostate cancer
International Journal of Urology, 10/15/09
Relevance Score: 66%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A heritable predisposition to pituitary tumors
Pituitary, 12/18/09
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique
Neurosurgical Focus, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor